Alexion
AcquiredAlexion Global Site
Boston, United States · Founded 1992
- Headquarters
- Boston, Massachusetts
- Employees
- 1001–5000
- Founded
- 1992
- Business Model
- B2B
- Website
- alexion.com
- Last Round
- SeedJun 1993
- Rounds
- 1
About
Rare disease pharmaceutical company specializing in complement biology and orphan drugs; AstraZeneca subsidiary since 2021.
Summary
Alexion is a Biotech company based in Boston, United States, founded in 1992. Its most recent funding was a Seed round in Jun 1993. Investors include AstraZeneca and Venrock.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2020
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company